Physician profile
Pyone Maung
NPI 1205866357
$1,798.68
in general payments reported to CMS, 2019-2025
21 companies · $81.06 in 2025
The $81.06 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,361 · 2020: $294 · 2021: $18.51 · 2023: $44.35 · 2025: $81.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $493.94 | 2019-2025 | Cabenuva, Dovato |
| Gilead Sciences, INC. | $324.51 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $210.68 | 2019-2020 | |
| Janssen Biotech, INC. | $135.63 | 2019 | |
| Merck Sharp & Dohme LLC | $93.30 | 2019 | |
| Abbvie INC. | $92.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $75.59 | 2019 | |
| Novo Nordisk INC | $58.80 | 2019-2020 | |
| Lilly USA, LLC | $53.36 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $41.44 | 2019 | |
| Pfizer INC. | $32.82 | 2019-2025 | |
| Atricure, INC. | $25.54 | 2020 | |
| Amarin Pharma, INC. | $23.73 | 2020 | |
| Daiichi Sankyo INC. | $23.71 | 2020 | |
| Abbott Laboratories | $19.61 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $19.06 | 2019 | |
| Mylan Institutional INC. | $17.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.21 | 2019 | |
| Napo Pharmaceuticals INC | $14.20 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.04 | 2019 | |
| Theratechnologies INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pyone Maung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.